Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00583934 | Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial? | completed | — | 19 | University of California, DavisOTHER | 1 | Jul 13, 2010 | clinicaltrials |
| NCT00453323 | Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer | unknown | Phase 2 | 33 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 12, 2010 | clinicaltrials |
| NCT01151839 | A Trial to Compare Preoperative Chemoradiation and Surgery Versus Surgery Alone in Squamous Cell Carcinoma of Oesophagus | unknown | N/A | 100 | All India Institute of Medical SciencesOTHER | 1 | Jul 12, 2010 | clinicaltrials |
| NCT01139229 | Hybrid-everted Versus Hand-sewn or Stapled Esophagogastrostomy in Prevention of Anastomotic Stricture | completed | N/A | 144 | Sichuan UniversityOTHER | 0 | Jun 8, 2010 | clinicaltrials |
| NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | completed | Phase 1 / Phase 2 | 30 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00876551 | Endoscopic-vacuum Assisted Closure of Intrathoracic Postsurgical Leaks(EVACoIL) | unknown | N/A | 30 | Hannover Medical SchoolOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT01053182 | Esophagectomy Associated Respiratory Complications: Ivor-Lewis Versus Sweet Approaches | unknown | Phase 3 | 320 | Sichuan UniversityOTHER | 1 | Jan 21, 2010 | clinicaltrials |
| NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | completed | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT01043016 | Safety Study of Photodynamic Therapy Using Photocyanine Injection in Treating Patients With Malignant Tumors | unknown | Phase 1 | 18 | Fujian Longhua Pharmaceutical Co. LtdOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT01034683 | Study of Lobaplatin,5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma | unknown | Phase 3 | 120 | Taian Cancer HospitalOTHER | 1 | Jan 5, 2010 | clinicaltrials |
| NCT01034332 | Paclitaxel/Cisplatin/Fluorouracil Followed by Paclitaxel/Cisplatin/Radiotherapy and Esophagectomy for Esophageal Cancer | unknown | Phase 2 | 58 | National Taiwan University HospitalOTHER | 1 | Dec 18, 2009 | clinicaltrials |
| NCT01034189 | Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer | unknown | Phase 2 | 62 | National Taiwan University HospitalOTHER | 1 | Dec 17, 2009 | clinicaltrials |
| NCT00220129 | Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus | completed | Phase 2 | 16 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT01032967 | Surgery or Chemoradiation for Esophageal Cancer | completed | Phase 3 | 40 | Chinese University of Hong KongOTHER | 0 | Dec 16, 2009 | clinicaltrials |
| NCT01033695 | Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes | completed | — | 74 | Odense University HospitalOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00066716 | Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus | completed | Phase 2 | 39 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 8, 2009 | clinicaltrials |
| NCT00160030 | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer | completed | Phase 2 | 97 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00259402 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00681330 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00681421 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00344552 | Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer | completed | Phase 2 | 53 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00995358 | A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer | unknown | Phase 2 | 60 | University of YamanashiOTHER | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165464 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | completed | Phase 2 | 54 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00215462 | Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00291473 | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00197444 | Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer | completed | Phase 2 | 33 | Hamamatsu UniversityOTHER | 1 | Feb 20, 2009 | clinicaltrials |
| NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00826813 | Trial Using 125I Embedded Stent in Patients With Advanced Esophageal Cancer | unknown | N/A | 250 | Southeast University, ChinaOTHER | 1 | Jan 22, 2009 | clinicaltrials |
| NCT00790140 | Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery | unknown | Phase 4 | 120 | University of Dublin, Trinity CollegeOTHER | 1 | Nov 13, 2008 | clinicaltrials |
| NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer(CONKO-101) | completed | Phase 2 | 92 | CONKO-StudiengruppeOTHER | 1 | Sep 26, 2008 | clinicaltrials |
| NCT00239200 | Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus | terminated | Phase 2 | 29 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 30, 2008 | clinicaltrials |
| NCT00003326 | Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus | unknown | Phase 2 | 100 | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00561275 | Safety Study of Multiple Peptide Vaccine to Esophageal Cancer | completed | Phase 1 | 6 | Japanese Foundation for Cancer ResearchOTHER | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00511264 | Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract | completed | — | 250 | Odense University HospitalOTHER | 1 | May 29, 2008 | clinicaltrials |
| NCT00682227 | Peptide Vaccination in Treating Patients With Esophageal Cancer | unknown | Phase 1 | 10 | University of YamanashiOTHER | 1 | May 29, 2008 | clinicaltrials |
| NCT00642239 | A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma | unknown | Phase 4 | 48 | Shandong Luye Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 14, 2008 | clinicaltrials |
| NCT00477841 | Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer | completed | Phase 2 | 60 | Southeast University, ChinaOTHER | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00642525 | Detection of Anastomotic Leakage After Esophageal Surgery | completed | N/A | 55 | Heidelberg UniversityOTHER | 1 | Mar 25, 2008 | clinicaltrials |
| NCT00001603 | The Effects of Upper Airway and Digestive Tract Tumors on the Immune System | completed | — | 93 | National Institute on Deafness and Other Communication Disorders (NIDCD)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00559351 | RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | terminated | Phase 3 | 84 | Ministry of Scientific Research and Information Technology, PolandOTHER_GOV | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00154804 | CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Aug 23, 2007 | clinicaltrials |
| NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | completed | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00335010 | Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction | completed | N/A | 32 | Erasmus Medical CenterOTHER | 1 | Jun 8, 2006 | clinicaltrials |
| NCT00318604 | Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker | unknown | — | — | Far Eastern Memorial HospitalOTHER | 0 | May 12, 2006 | clinicaltrials |
| NCT00197431 | Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer | unknown | Phase 2 | — | Hamamatsu UniversityOTHER | 1 | Mar 22, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Jul 13, 2010source: clinicaltrials